During the past decade, Cheshire Medical Center-Dartmouth-Hitchcock Keene conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 19 clinical trials were completed, i.e. on average, 633.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 7 clinical trials were completed. i.e. 700% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cheshire Medical Center-Dartmouth-Hitchcock Keene" #1 sponsor was "National Cancer Institute (NCI)" with 19 trials, followed by "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "CairnSurgical, Inc." with 1 trials sponsored, "Dartmouth-Hitchcock Medical Center" with 1 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cheshire Medical Center-Dartmouth-Hitchcock Keene" #1 collaborator was "Cancer and Leukemia Group B" with 5 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator, "National Cancer Institute (NCI)" with 4 trials as a collaborator and "North Central Cancer Treatment Group" with 4 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Cheshire Medical Center-Dartmouth-Hitchcock Keene" are "Recurrent Breast Carcinoma" (5 trials), "Breast Adenocarcinoma" (3 trials), "Stage IIA Breast Cancer AJCC v6 and v7" (3 trials), "Stage IIB Breast Cancer AJCC v6 and v7" (3 trials) and "Stage IIIA Breast Cancer AJCC v7" (3 trials). Many other conditions were trialed in "Cheshire Medical Center-Dartmouth-Hitchcock Keene" in a lesser frequency.

Most popular intervention types in "Cheshire Medical Center-Dartmouth-Hitchcock Keene" are "Drug" (21 trials), "Other" (17 trials), "Biological" (14 trials), "Radiation" (6 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (14 trials), "Quality-of-Life Assessment" (8 trials), "Bevacizumab" (6 trials), "Paclitaxel" (6 trials) and "Exemestane" (4 trials). Other intervention names were less common.

The vast majority of trials in "Cheshire Medical Center-Dartmouth-Hitchcock Keene" are 15 trials for "All" genders, 9 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Cheshire Medical Center-Dartmouth-Hitchcock Keene". undefined are not yet recruiting, 1 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Cheshire Medical Center-Dartmouth-Hitchcock Keene, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cheshire Medical Center-Dartmouth-Hitchcock Keene, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Cheshire Medical Center-Dartmouth-Hitchcock Keene has several departments that took part in Clinical trials: "Kingsbury Center for Cancer Care at Cheshire Medical Center" - 23 trials